Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity.

Pretargeting techniques using the avidin-biotin system have shown encouraging results in both diagnostic and therapeutic clinical trials. It has been shown that in cancer therapy the ideal agent to be used for pretargeting should have a plasma half-life longer than avidin and lower immunogenicity th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chinol, M., Casalini, P., Maggiolo, M., Canevari, S., Omodeo, E. S., Caliceti, P., Veronese, F. M., Cremonesi, M., Chiolerio, F., Nardone, E., Siccardi, A. G., Paganelli, G.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062912/
https://www.ncbi.nlm.nih.gov/pubmed/9683292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062912/
https://www.ncbi.nlm.nih.gov/pubmed/9683292

Ejemplares similares